Malignant Tumors of the Lung
Subtitle: Evidence-based Management
Contributors: Jean-Paul Sculier (Editor); Willard A. Fry (Editor)
Edition: 1 edition
Publisher: Springer
Published: December 5, 2003
Language: eng
Format: Hardcover
Number of pages: 442
ISBN-13: 9783540438878
Subjects: Oncology; Respiratory medicine; Pulmonary & Thoracic Medicine; Medical / Nursing; Lung Neoplasms; therapy; Medical; Radiology; Medical / Oncology; Carcinoma, Non-Small-Cell Lung; Cancer; Lungs
First sentence: Lung carcinoma is currently perceived to be the result of complex mutational and epigenetic changes in the epithelial cells of the lung that impart to those cells a high capacity for proliferation, resistance to programmed cell (apoptosis), the ability to invade and destroy normal tissue and the capacity to metastasize.
Description: This textbook synthesizes the basic science of lung cancer with the state-of-the-art accounts of diagnosis and treatment. Written by a distinguished panel of experts from Europe, Asia, and North America, it covers all of the most important fields: biology, pathology, epidemiology, screening, diagnosis, therapy, supportive care, and prognosis. All physicians caring for patients with lung cancer, especially surgeons, chest physicians, radiation oncologists, and medical oncologists, will find a wealth of information that meets their needs. Whenever possible, the principles of evidence-based medicine are followed by providing data from systematic reviews, metaanalyses, methodology-based guidelines, and randomized clinical trials.